Results 91 to 100 of about 14,200 (285)
Treatment of diverticular disease: an update on latest evidence and clinical implications [PDF]
, 2018 Background: Diverticular disease (DD) is a common condition, especially in Western countries. In about 80% of patients, colonic diverticula remain asymptomatic (diverticulosis), while approximately 20% of patients may develop abdominal symptoms ...
Annibale, B, Carabotti, M
core +2 more sources
JPGN Reports, Volume 6, Issue 4, Page 437-443, November 2025.Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant +3 more
wiley +1 more source
The plot thickens: A pediatric cases series on collagenous gastritis
JPGN Reports, Volume 6, Issue 4, Page 368-371, November 2025.Abstract Objective Collagenous gastritis (CG) is a rare gastrointestinal disorder characterized by the deposition of collagen in the sub‐epithelium of the gastric mucosa. CG can cause a variety of symptoms including iron deficiency anemia, abdominal pain, dyspepsia, vomiting, and weight loss.
Annemarie Rompca +3 more
wiley +1 more source
Capsule endoscopy in inflammatory bowel disease type unclassified and indeterminate colitis serologically negative [PDF]
, 2010 BACKGROUND: The value of capsule endoscopy in the setting of inflammatory bowel disease type unclassified (IBDU) and indeterminate colitis (IC) remains obscure.
Almeida, N +7 more
core +1 more source
Mesalamine induced hepatotoxicity. Is mesalamine safe?
Revista Española de Enfermedades DigestivasDear Editor: Mesalamine is a medication used widely in the treatment of patients with inflammatory bowel disease. Although mesalamine is considered safe, hepatotoxicity has been reported with an incidence of 0-4%. We present the clinical picture of a patient with hepatotoxicity due to mesalamine.
Javier, Pérez-Valenzuela +3 more
openaire +2 more sources
United European Gastroenterology Journal, Volume 13, Issue 9, Page 1776-1786, November 2025.ABSTRACT Background Few data are available on the impact of primary sclerosing cholangitis (PSC) on inflammatory bowel disease (IBD). Objective We conducted a retrospective study using TriNetX to compare the outcomes of patients with IBD and those with concomitant IBD and PSC.
Ferdinando D'Amico +14 more
wiley +1 more source
Water-in-Water Emulsion as a New Approach to Produce Mesalamine-Loaded Xylan-Based Microparticles
Applied Sciences, 2019 The water-in-water emulsion method has been reported as a technique able to prepare microparticles without using harmful solvents. However, there are few reports showing the encapsulation of small molecules into microparticles produced within this ...
Bartolomeu S. Souza +6 more
doaj +1 more source
Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
Patient Preference and Adherence, 2009 Daniel B Zandman, Mark A PeppercornHarvard Medical School, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Mesalamine and its derivatives are effective and well-tolerated therapies for ...
Daniel B Zandman, Mark A Peppercorn
doaj
Infection and Drug Resistance, 2023 Zhi Wang,1,* Li Yang,2,* Shan Sun2 1Pediatric Gastrointestinal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China; 2Gastroenterology, Sinopharm Dongfeng General Hospital, Hubei ...
Wang Z, Yang L, Sun S
doaj
mSphere, 2020 Colibactin induces DNA damage in mammalian cells and has been linked to the virulence of Escherichia coli and the promotion of colorectal cancer (CRC). By looking for mutants attenuated in the promoter activity of clbB encoding one of the key enzymes for
Min Tang-Fichaux +5 more
doaj +1 more source